Mani, Inc. Provides Consolidated Earnings Guidance for the Second Quarter and Year Ending August 31, 2024
January 12, 2024 at 01:30 am EST
Share
Mani, Inc. provided consolidated earnings guidance for the second quarter and year ending August 31, 2024. For the quarter, the company expects net Sales to be JPY 13,350 million, operating income to be JPY 4,050 million, profit attributable to owners of parent to be JPY 2,900 million and earnings per share to be JPY 29.44.
For the year, the company expects net Sales to be JPY 27,500 million, operating income to be JPY 8,250 million, profit attributable to owners of parent to be JPY 5,900 million and earnings per share to be JPY 59.90.
Mani Inc is a Japan-based company mainly engaged in the manufacture and sale of medical equipment. The Company operates through three business segments. The Surgical-related Product segment is engaged in the provision of surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment. The Eyeless Needle-related Product segment is engaged in the provision of eyeless surgical suture needles. The Dental-related Product segment is engaged in the manufacture and sale of dental root canal treatment equipment, such as reamers, files, broaches and cleansers; grinding and abrasive agents, such as carborundum points and silicone points; rotating dental treatment equipment, such as diamond burs, carbide burs, stainless burs and others, as well as dental materials, dental stereomicroscopes, among others.
MANI, INC. 
